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Abstract 
Carbohydrates are important to cellular communication, recognition, and pathogenesis, 
making them a useful synthetic target for application in therapeutics and diagnosis. Synthetic 
carbohydrate presenting scaffolds can replicate or interrupt the binding interactions that 
occur in nature. Due to the weak nature of the monosaccharide-protein bond, most 
carbohydrate presenting scaffolds display saccharides in a multivalent manner to improve 
binding. Recently there has been an effort to combine carbohydrate containing scaffolds with 
polymersomes (vesicles composed of polymers), due to the structural resemblance of 
polymersome membranes to biological membranes. This thesis describes the progress 
towards functionalizing polymersomes with linear glycopolymers as a potential method to 
achieve improved multivalent binding. A novel b-D-Galactose containing polymer was 
synthesized using reversible addition-fragmentation chain transfer polymerization. This 
polymer, as well as a previously reported glycopolymer based on a polyacrylamide backbone 
were labeled with rhodamine in order to quantify their subsequent conjugation to the 
polymersome surface. Two different vesicle platforms were investigated, polybutadiene-b-
poly(ethylene glycol) and poly(ethylene glycol)-b-poly(ethyl glyoxylate)-b-poly(ethylene 
glycol). The experiments suggested that it is possible to conjugate the glycopolymers to the 
polymersome surfaces to obtain different glycopolymer densities and quantify the reaction 
yields using fluorescence spectroscopy. Future work will involve binding studies of the 
glycopolymer-coated vesicles to carbohydrate binding proteins (lectins). 
Keywords 
Carbohydrates, glycopolymers, carbohydrate scaffolds, polymersomes, vesicles, surface 
functionalization, RAFT, multivalency. 
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Chapter 1  
1 Carbohydrates and their Role in Therapeutics 
 
1.1 Introduction to Carbohydrates 
 
1.1.1 Carbohydrates and their role in Nature 
Carbohydrates or saccharides play a crucial role in cellular adhesion and molecular 
signaling that occurs at the surfaces of many mammalian and microbial cells.1,2 The 
interactions between cells and the surrounding extracellular matrix (ECM) are regulated 
by cellular adhesion events that fall under one of three interaction types: protein-protein, 
protein–carbohydrate, and carbohydrate–carbohydrate interactions. These interactions 
control the binding of connective proteins that form the ECM.3 Carbohydrates displayed 
on the surfaces of cells act as identifying molecules that inform cells of their respective 
type, thereby allowing for cellular organization and the formation of homogeneous-
multicellular tissue.4,5 Signaling molecules regulate the immune response, cancer 
metastasis, and act as indicators for disease states in the human body.5 
 
1.1.2 Carbohydrates and the Human Immune System 
The innate and adaptive immune systems mimic key interactions between displayed 
carbohydrates and complimentary binding proteins on the surface of mammalian cells 
and pathogens in order to fight infection. The innate immune system is the part of the 
immune system that can protect the body from a wide variety of pathogens. It is partially 
composed of different types of phagocytes that can consume and destroy pathogens. For 
example, macrophages can identify and trap a virion by multiple carbohydrate-based 
mechanisms.5 Mannose Binding Proteins (MBPs) found in the blood stream can bind to 
mannose residues displayed on the surface of a virion to form a complex.6 MBP-virion 
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complexes can then associate with receptors on the surface of the macrophage to trigger 
phagocytosis (Figure 1.1).5,7 Phagocytosis can also be triggered by the binding of sialic 
acid residues displayed on a macrophage’s surface sialic acid binding proteins (SABP) or 
long linear pendent protein chains to virion surface proteins8; sialic acid functionalized 
protein chains act like a net in the blood stream, attempting to capture pathogens that do 
not make direct contact with the macrophage’s surface.5 
 
 
Figure 1.1. Binding of viruses to a macrophage presenting MBP-Receptors and SABP’s 
to induce phagocytosis and an immune response. 
Although the innate immune system provides defense against many invading pathogens, 
the adaptive immune system allows for a long term and larger immune response than the 
innate system. Dendritic cells, a type of phagocyte from the innate immune system, 
display fragments of glycoproteins or glycolipid complexes that were derived from a 
previously consumed virion. Specialized lymphocytes interact with the presented 
fragments and use the information to trigger an immune response. A dissimilar immune 
response targeting the human body’s own cells can be triggered by abnormal or 
pathogenic carbohydrate displays on the surface of human cells. 
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1.1.3 Carbohydrates and Cancer 
The body can identify cancerous cells by the aberrant presentation of carbohydrates on 
the surface of the cell.9 Malignant cancer cells often have different carbohydrates 
presented due to the fact that they have different cellular adhesion and mobility than 
typical cells.10 Increased glycosylation of surface glycoproteins has been observed in 
multiple types of cancer including breast, prostate, and pancreatic cancers.10 Higher 
degrees of glycosylation have been speculated to increase the ability of tumors to 
metastasize by improving binding of the cancerous cells to the walls of blood vessels.10 
Unique and cancer specific antigens are displayed by cancerous cells.11 Thus, these 
antigens have been considered to be a useful target for potential cancer vaccines or 
targeted drug delivery. Carbohydrates have widely been hailed as potential therapeutics 
but to understand the design of such therapeutics, a closer look at the nature of 
carbohydrate bonds is required.  
 
1.2 The Nature of Carbohydrate Binding 
 
1.2.1 Carbohydrate–Protein Binding 
Carbohydrates typically bind to proteins and other carbohydrates through weak 
intermolecular forces. When binding to proteins, carbohydrates typically bind either in 
pockets or grooves on the surface of a protein. Pockets only allow specific saccharides 
with a certain conformation to favourably bind (Figure 1.2); grooves offer a less specific 
binding. Non–covalent hydrogen bonding of saccharide hydroxyl groups to aspartic acid, 
asparagine, glutamic acid, glutamine, and arginine residues are the most important and 
strongest binding interactions.12,13 The formation of new hydrogen bonds is important to 
the spontaneous binding of saccharide to proteins. However, to understand the binding of 
mono-, oligo- or polysaccharides to proteins, driving forces other than hydrogen bond 
formation must also be introduced.13 
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Figure 1.2. Schematic illustrating the effect of binding of galactose to a binding pocket. 
b-galactose favourably binds to the protein where α-galactose does not bind favourably 
due to steric hindrance.12 
 
The spontaneous binding of carbohydrate presenting molecules to complimentary lectins 
is assumed to be a model system for carbohydrate-protein binding interactions. “Lectins 
are proteins of nonimmune origin that bind to specific carbohydrates without modifying 
them,” and have been found in most microorganisms and multi-cellular organisms.5,13 In 
a binding interaction, initially both the carbohydrate and site of binding are solvated, 
typically with water molecules. The water molecules at the site of binding are suspected 
to be highly ordered and in a higher-energy state than water molecules interacting in 
bulk.13 When the carbohydrate hydroxyl groups interact with amino acid residues at the 
site of binding, the high-energy water molecules are displaced, and become lower in 
energy.13,14 The breaking of the hydrogen bonds contributes a small negative ∆H term to 
∆G, in ∆G = ∆H -T∆S, where a negative ∆G indicates spontaneous binding. There is an 
enthalpic cost associated with the formation of new water–water hydrogen bonds, but it is 
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compensated for by the slightly larger entropic contribution of solvent rearrangement to 
∆S.15 The rearrangement of highly–ordered water molecules surrounding the hydrophobic 
portions of the carbohydrate and lectin binding site to disordered water molecules is 
highly favours entropy. Thus, solvent rearrangement is the main driving force behind 
carbohydrate–lectin binding.13,15 The binding site favours the binding of a specific 
conformation of the carbohydrate, but conformational binding and locking reduces the 
rotational freedom of the carbohydrate bonds. This reduction in rotational freedom is 
associated with a small entropic cost that makes ∆G slightly less negative. 
Monosaccharide-lectin binding is determined by the above enthalpic and entropic 
interactions.4 Oligosaccharides and molecules that present multiple copies of a saccharide 
have a more favourable binding to lectins due to the multivalent effect. 
 
1.2.2 Multivalent Carbohydrate Binding to Lectins 
The increased binding of oligosaccharides, glycopolymers, glycoproteins, and glycolipids 
in biological systems may offer an explanation for why many key binding interactions 
rely on molecules displaying multiple carbohydrates. One reason multivalent 
carbohydrate binding moieties may have stronger interactions with lectins, is that lectins 
and some other proteins contain multiple binding sites.13 For example, in the binding of 
glycopolymers, an entropic cost is initially paid when one of the saccharides adapts the 
required binding conformation; flexible and freely rotating glycopolymers have more 
entropy than bound glycopolymers.13 Other saccharides on the glycopolymer are now 
free to bind to another site on the lectin without paying the same initial entropic cost, 
increasing the favourability of the second saccharide binding event. Upon binding of a 
multivalent carbohydrate there may also be a large local concentration of saccharides, 
contributing to the multivalent effect. After a single saccharide binds to the 
complementary lectin, many saccharides populate the local environment, shifting the 
equilibrium to favour binding. It can be imagined that either interactions with another 
binding site, or interaction with the same binding site, after disassociation, would be 
possible.5,13 The multivalent effect on binding is expected to be driven by a combination 
of entropic and concentration–based effects.4 Due to the increased binding and 
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prevalence of polyvalent carbohydrates in nature, many therapeutic scaffolds taking 
advantage of the multivalent effect have been proposed over the years. 
 
1.3 Carbohydrate Presenting Scaffolds for use in 
Therapeutics 
 
1.3.1 Naturally Occurring Glycopolymers 
Scaffolds presenting polyvalent carbohydrates are often designed to replicate 
carbohydrate presentation in nature. A natural glycopolymer that has been shown to have 
many therapeutic applications is hyaluronan, a derivative of hyaluronic acid (Figure 1.3). 
Hyaluronan is a glycopolymer found in many living organisms and in the ECM of 
cartilage in humans.16 It has applications in ophthalmology, treatment of osteoarthritis, 
and wound healing, where the hyaluronan often acts as a lubricant or moisturizer.17 
Hyaluronan can be modified through semi-synthetic methods to alter the properties. 
However, synthetic glycopolymers offer distinct advantages over natural or semi-
synthetic glycopolymers.  
 
 
Figure 1.3. Structure of Hyaluronic Acid, a natural glycopolymer. 
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1.3.2 Synthetic Glycopolymers 
Synthetic glycopolymer scaffolds have been developed to control structural properties 
including molar mass and the presented saccharide. A high degree of variability in molar 
mass (number of presented saccharides) within a particular glycopolymer sample, or a 
polydisperse sample, increases the variability of action for biological applications. In 
contrast, monodisperse samples, or samples with a low degree of variability in molar 
mass, have reproducible properties and less therapeutic variability.5,18 Glycopolymers 
with a molar mass under 100,000 g/mol have been shown to avoid stimulating parts of 
the immune system, creating greater specificity of action.10 The carbohydrate presented 
often determines the application of a glycopolymer. For example, the Influenza A virus is 
coated in proteins that specifically bind to sialic acid.5,19,20 A natural glycopolymer 
containing sialic acid residues, mucin, can neutralize a virus as seen in Figure 1.4 (a). 
Tsuchida and co-workers took advantage of this and designed a synthetic glycopolymer 
with sialic acid residues to neutralize the infectious capability of viral particles as shown 
in Figure 1.4.20 Short synthetic glycoproteins, or glycosylated polypeptide sequences, 
have been shown to have similar neutralization potential to viral particles.21  
 
Figure 1.4. (a) Neutralization of an influenza virus with mucin, a natural glycoprotein 
containing sialic acid groups. The mucin inhibits binding of the virus to the cell, 
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preventing invasion. Modified and reprinted with permission.19 (b) Structure of sialic acid 
glycopolymer derivative used to neutralize Influenza A. 
 
1.3.3 Glycopeptides 
Glycopeptides are synthetic glycopolymers based on peptide linkages between 
glycosylated amino acid derivatives. Peptide synthesis involves sequential deprotection 
and protection steps leading to discrete peptide sequences which improves the 
reproducibility of experimental results.22 Control over the peptide sequencing allows for 
the fine tuning of distances between binding groups and can change the presented 
carbohydrate patterns.23 For example cyclic glycopeptides present carbohydrates in a 
unique manner (Figure 1.5).21 Synthetic glycoproteins, as a class of scaffolds, are 
generally highly biocompatible due to the fact that most organisms possess the enzymes 
to break down peptide linkages. 
 
Figure 1.5. (a) Sialylated lactose cyclic glycopeptide shown to neutralize Influenza A.21 
(b) Pentasaccharide core of N-glycans.24 
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1.3.4 Glycoconjugates 
Glycoconjugates are another biocompatible scaffold that use glycosylated proteins, 
antibodies, or antigens as therapeutics. The term glycoconjugate refers to any protein or 
antibody that has a glycopolymer, oligosaccharide, or glycopeptide covalently bound, or 
conjugated, to its surface to improve its targeted delivery.5 N-glycans are an example of 
naturally occurring glycoconjugates. N-Glycans have the same pentasaccharide core as 
shown in figure 1.5 with functionalization of the hydroxyls observed.24 Although 
glycoconjugates show potential for a wide variety of applications, available synthetic 
transformations are limited to reaction conditions that will not destroy the biological 
activity of the protein.24,25 Glycosylation reactions often require anhydrous conditions 
which are incompatible with many proteins.23 The present synthesis of glycoconjugates, 
like N-glycans, relies on enzymatic transformations which have issues of site-specific 
reactivity.24,25 Despite difficulties with synthesis, glycoconjugate therapeutics have been 
developed. For example, branched glycoproteins conjugated to a protease that could 
cleave a specific receptor on a bacterial pathogen. The glycoconjugate of the protease 
showed an improvement in efficacy by 103 over the protease.5  
 
1.3.5 Glycodendrimers 
Glycodendrimers are a class of branched glycopolymers that are both well-defined and 
present carbohydrates in a multivalent manner.26 The molecule typically branches away 
from a central point with selected reactive or functional groups at the outer terminus.26 
Dendrimers are often synthesized generationally using a series of protection, coupling, 
and deprotection steps similar to polypeptides.7,27 Each growth step increases the 
generation and branching of dendrimers, where G0 is the initial generation and the third 
generation, G3, has had at least three growth steps increasing the branching.  These 
discrete generational synthetic steps lead to high degrees of control over the size and 
consequently the size dependent properties. The effect of dendrimer generation and 
number of presented saccharide units was observed in a study by André et al. where they 
tested lactose functionalized glycodendrimers as an inhibitor of  (AB)2-toxic agglutinin, a 
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toxic lectin found in mistletoe.28 Glycodendrimers of generation G3-G5, displayed 32 
(Figure 1.6) to 128 lactose molecules, which showed a 10 to 100 fold increase in relative 
inhibition potency over lower generation dendrimers, G0-G2, which displayed 4 to 16 
lactose molecules.28 A high-density of terminal functional groups increases binding 
affinity for certain systems. 18  
 
 
Figure 1.6. Structure of the lactose–functionalized starburst glycodendrimer synthesized 
by André et al.28 
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1.3.6 Carbohydrate Functionalized Nanoparticles 
Functionalized nanoparticles composed of gold, iron oxide, and other semi-conductive 
metal nuclei have been functionalized with carbohydrates creating the field of 
glyconanoparticles.29 The metallic nucleus of a glyconanoparticle gives the particle 
inherent magnetic and electrochemical properties, and the use of a radionuclide makes a 
glyconanoparticle a multimodal imaging scaffold.29 Goldnanoparticles (GNP) 
functionalized with lactose, Figure 1.7, showed strong binding to galectin-1, a 
mammalian b-galactoside-specific lectin.30 An overcrowding effect was observed with 
the lacto-GNP, where a decreased binding to the lectin was associated with 100 percent 
surface functionalization.30 Similar lacto-GNP were applied in anti-adhesion therapy in 
mice.31,32 The metastasis of a melanoma cell line in mice treated with lacto-GNP was 
inhibited up to 70% in comparison to untreated mice.32 Cationic glycopolymer 
functionalized GNPs have shown potential as gene delivery vehicles. The particles had a 
transfection efficiency of approximately 55 %.33  
12 
 
 
Figure 1.7. Simplified representation of a lactose–functionalized goldnanoparticle.30 
 
1.4 Carbohydrate Presenting Assemblies and their 
Applications 
 
1.4.1 Micelles 
Nano-assemblies composed of amphiphilic molecules have been of interest to scientists 
for many years due to their abilities to encapsulate a variety of hydrophilic and 
hydrophobic cargo and their ability to mimic cell membranes.34 Amphiphilic molecules 
can spontaneously self-assemble to form unique morphologies, usually determined by the 
hydrophilic weight fraction of the molecule.34 Micellar morphologies have been observed 
from the self-assembly of amphiphilic glycopolymers. For example, Suriano et al. 
synthesized a galactose–functionalized polycarbonate block copolymer using ring 
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opening polymerization (Figure 1.8 (a)). From the block copolymer they were able to 
form micelles that could be loaded with doxorubicin, an anti-cancer drug. The galactose-
functionalized micelles showed specific uptake into liver carcinoma cells (HepG2) over 
glucose functionalized analogues. The results therefore indicated the potential for 
targeted delivery of anti-cancer drugs using glyco-assemblies.35 The micellar morphology 
allows for the loading of hydrophobic cargo, however hydrophilic cargo may be loaded 
into a variety of other assembly morphologies. 
 
Figure 1.8. (a) Self–assembly of galactose-functionalized amphiphilic polycarbonate-
based polymer into a micelle loaded with hydrophobic cargo.35 (b) Self–assembly of 
PGalSMA amphiphilic block copolymer or a twin-twin amphiphilic glycodendrimer into 
a vesicle loaded with hydrophobic and hydrophilic cargo.36,37  
 
1.4.2 Polymersomes 
A vesicle morphology is observed when a bi-layer is formed during the self-assembly of 
amphiphilic molecules. Vesicles have been observed to result from the self-assembly of 
lipids, dendrimers, and block copolymers.38,39 Polymethacrylate block copolymers 
14 
 
conjugated with galactose (PGalSMA) have been synthesized using reversible addition–
fragmentation chain–transfer (RAFT) polymerization. RAFT is a method of controlled 
polymerization that can afford monodisperse polymer samples, or samples that contain 
polymer chains all of similar molecular weight.40 Monodisperse polymer samples are 
important for self–assembly due to the sensitive nature of the hydrophilic–hydrophobic 
ratio that determines assembly morphology. It is common for amphiphilic block 
copolymers used in therapeutic scaffolds, PGalSMA for example, to be synthesized using 
RAFT polymerization to improve reproducibility and reliability.41 PGalSMA has been 
shown to assemble into vesicles (Figure 1.8 (b)).36 A hydrophilic rhodamine-based dye 
that cannot normally undergo cellular uptake was loaded into the PGalSMA vesicles. 
Staining of internal cellular organelles indicated cellular uptake and successful cargo 
delivery. 36 
 
1.4.3 Dendrimersomes 
Percec and coworkers have synthesized Janus glycodendrimers using a modular strategy 
that allowed the authors to produce vast libraries of glycodendrimers.38 The libraries 
enabled them to determine the effects of crystallinity, saccharide, and linker lengths on 
assembly morphology.37 Glycodendrimers with a variety of saccharides were able to form 
giant glycodendrimersomes, which are assemblies of micrometer-scale. Due to their size, 
bi-layer membrane, and multivalent presentation of surface carbohydrates, the 
glycodendrimersomes were presented as a new potential cellular mimic.38 Gillies and co-
workers synthesized a-galactose-presenting glycodendrimers which could self–assemble 
into vesicles. These a-galactose glycodendrimersomes were able to stimulate invariant 
natural killer T (iNKT) cells.27 iNKT cells are normally stimulated by a-galactose 
presented in a multivalent manner, which is associated with pathogenesis.27 Self-
assemblies displaying carbohydrates in a multivalent manner provide a unique 
opportunity to act as delivery agents and biological mimics for use in therapeutics and the 
study of biological activity. 
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1.5 Thesis Objectives 
 
1.5.1 Project Background 
In previous work by the Gillies group, polymersomes were functionalized with 
dendrimers using a copper–catalyzed azide–alkyne cycloaddition (CuAAC) 
reaction.39,42,43 It was determined that post-assembly modification of polymersomes using 
CuAAC did not disrupt the assembly morphology.42 Varying degrees of surface 
functionalization were possible by altering the ratio of azide-functionalized to 
unfunctionalized amphiphilic polymer used to form the polymersomes.39,42,43 The Gillies 
group successfully functionalized polybutadiene-b-poly(ethylene oxide) (PBD-b-PEO) 
polymersomes with sialic acid derivatized glycodendrimers.7 These glycodendrimer 
functionalized assemblies were shown to bind well to complimentary lectin but the ability 
of the assemblies to prevent the binding of influenza A viruses to mammalian cells was 
found to be limited. This was believed to result from the rigidity of the glycodendrimer 
structures. It can be imagined, that when surrounding a spherical virus with other spheres, 
the area of contact would be relatively limited. Because of the previous results, it was 
speculated that an improvement in binding could be achieved by introducing flexible 
linear glycopolymers to the surfaces of the polymersomes. This would instead allow 
octopus-like structures to surround the virus. Given the role of carbohydrates in 
numerous biological processes, it was proposed that glycopolymer-functionalized 
polymersomes could potentially serve as multivalent inhibitors of viral infection, 
vaccines, or targeted drug delivery vehicles that would resemble cell membranes. In 
addition, they could simultaneously serve as carriers for hydrophobic and hydrophilic 
cargo such as drugs or imaging agents. The surface functionalization density and 
glycopolymer chain length may also give important information about the optimal 
surface structure for lectin binding. 
 
In unpublished Gillies group work, the successful polymerization of an acrylamide 
functionalized ß-galactose monomer using RAFT had been achieved.44 Small quantities 
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of alkyne terminated low molecular weight polymer, high molecular weight polymer, and 
monomer were previously synthesized and available for test reactions. The alkyne end-
group of the polymer could potentially undergo a CuAAC reaction with azide 
functionalized PBD-b-PEG polymersomes (Figure 1.9). PBD-b-PEG was chosen as the 
amphiphilic block co-polymer because it has previously been used to produced vesicles 
using the film-hydration method.42 Film hydration was selected as a method of self-
assembly because it allows for the facile encapsulation of both hydrophobic and 
hydrophilic cargo, while generally avoiding bio-incompatible organic solvents. 
Preliminary experiments had been performed to investigate the coupling of the linear 
polymers onto the vesicles. 
 
Figure 1.9. Schematic showing the method for functionalizing polymersomes with 
glycopolymers. 
 
1.5.2 Project Objectives 
For this thesis, it was proposed to prepare and study four different functionalized 
polymersome systems to examine the effects of both glycopolymer chain length and 
density on binding to lectin. Low and high densities of short and long polymers were 
Vesicles with Azide
Functional Group
Glycopolymer 
Functionalized 
Vesicles
CuAAC
Alkyne Terminated
Glycopolymer
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proposed (Figure 1.10). Efficacy of the CuAAC reaction between the polymersomes and 
glycopolymers needed to be quantified to make accurate conclusions about the effect of 
glycopolymer density on binding.39,42,43 It was proposed that this could be accomplished 
using a similar method as shown in Figure 1.9 above, but with dye-labeled 
glycopolymers. This thesis describes the progress towards these goals.  
 
 
Figure 1.10. Diagram showing the four degrees of glycopolymer functionalization 
targeted. 
Short Glycopolymer – High DensityShort Glycopolymer – Low Density
Long Glycopolymer – High DensityLong Glycopolymer – Low Density
18 
 
Chapter 2  
2 Results and Discussion 
 
2.1 Synthesis and Characterization of Glycopolymers 
 
In prior work by the Gillies group, polyacrylamides with terminal alkynes and pendant 
galactose moieties had been synthesized with two different degrees of polymerization 
(DPn) and consequently two different number average molar masses (Mn). A RAFT 
polymerization approach had been used to provide glycopolymers with low dispersities 
(Đ). 200 mg of PAGal9 (DPn ~9, Mn = 2,400 g/mol, Đ = 1.2, based on size exclusion 
chromatography (SEC) in water) and 100 mg of PAGal19 (DPn ~19, Mn = 5,200 g/mol, Đ 
= 1.3) were available for test reactions on polymer vesicle surfaces.44 To quantify the 
extent of reaction with the vesicle surface, a fluorescent dye was conjugated to each of 
PAGal9 and PAGal19 (Scheme 2.1). This was accomplished using a N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC.HCl) coupling reaction 
in the presence of 4-dimethylaminopyridine (DMAP) to react the carboxylic acid group 
of rhodamine B with a small number of the hydroxyl groups of the pendant b-galactose 
moieties. It was desirable to modify only a small fraction of the sugars to minimize the 
structural modification of the polymer and therefore reduce any impact of the dye 
molecules on the properties of the conjugated glycopolymers. The product was purified 
by dialysis against water using a 1,000 g/mol molecular weight cut-off (MWCO) 
membrane. 
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Scheme 2.1. Synthetic scheme for the coupling of rhodamine B onto PAGal. 
 
The 1H NMR spectra of the rhodamine functionalized polymers PAGal9-Rho and 
PAGal19-Rho had a new broad peak in the aromatic proton region that were 
characteristic of the rhodamine dye, indicating the successful coupling of rhodamine onto 
the polymer (Figure 2.1). Based on the relative integrations of peaks at ~7.5 ppm and 
~4.3 ppm in the 1H NMR spectra, the rhodamine was conjugated in ~7% molar 
equivalents for PAGal9-Rho and ~9% molar equivalents for PAGal19-Rho, compared to 
the individual repeat units. 
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Figure 2.1. 1H NMR spectra of PAGal9-Rho showing the characteristic rhodamine dye 
peak (600 MHz, DMSO-d6). 
 
Polymers PAGal9 and PAGal19 were suitable for test quantification reactions but for the 
lectin binding tests more of these polymers were required. Consequently, more of 
monomer needed to be synthesized and polymerized. To accomplish this, replication of 
the synthesis shown in Scheme 2.2 was attempted.44 First, the pentaacetate-protected D-
galactose was synthesized by the reaction of D-galactose refluxing acetic anhydride in the 
presence of sodium acetate. The D-galactose pentaacetate was then selectively 
glycosylated with azido ethanol using boron trifluoride etherate to afford the b-anomer of 
compound 1. A saccharide-based impurity, < 10% by H NMR, suspected to be D-
galactose pentaacetate, was observed in a 1H NMR spectrum of ‘purified’ compound 1. 
After multiple attempts to purify compound 1 further using column chromatography, the 
synthesis was continued with the hope that purification at a later step would be possible. 
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The azide group in compound 1 was reduced using Lindlar’s catalyst, Pt on CaCO3 
poisoned with 5% Pb, suspended in ethanol in a hydrogen gas environment. To avoid a 
reaction of the newly formed amine group and the acetyl protecting group, para-toluene 
sulphonic acid was used as a temporary protecting group by forming the ammonium salt, 
compound 2. In the final step, to afford monomer AAcGal, the ammonium group was 
deprotonated with excess N,N-diisopropylethylamine (DIPEA) allowing for the formation 
of the amide with the acryloyl chloride.  
 
 
Scheme 2.2. Synthesis of monomer AAcGal, b-D-galactose pentaacetate functionalized 
acrylamide monomer. 
 
A high degree of difficulty with the synthesis and purification at the final step of 
synthesizing monomer AAcGal was experienced. The TLC of crude AAcGal showed 
multiple products with 3 spots staining with ninhydrin, indicating the presence of an 
amine or amide. After collecting what seemed to be the product containing fractions from 
column chromatography, the 1H NMR spectrum still indicated the presence of impurities 
which were not removed upon re-purification with column chromatography. It should be 
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noted that after the first column, the yield dropped from ~14 g of crude product to ~ 4 g. 
It had been previously reported in unpublished Gillies group work that this acrylamide 
monomer was exceptionally reactive and could auto polymerize. Butylate hydroxytoluene 
(BHT), a radical inhibitor, was added to the eluent to prevent auto-polymerization, but 
the drastic decrease in yield could still be attributed to auto-polymerization of the 
monomer on the column and removal of the impurities present in the crude product. The 
vinyl proton shifts in the 1H NMR spectrum under-integrated relative to what was 
expected for the product, supporting the hypothesis that auto-polymerization could have 
occurred. The final synthetic step for monomer AAcGal was repeated two more times 
with freshly distilled acryloyl chloride, DIPEA, and CH2Cl2. It has previously been stated 
in the literature that “The synthesis, isolation, and purification of glycomonomers is 
notoriously difficult.” 36  
 
Due to the difficulty with replicating the synthesis of monomer AAcGal, synthesis of a 
new styrenic monomer, SAcGal, was explored (Scheme 2.3). In the first step, propargyl 
alcohol was deprotonated with sodium hydride in anhydrous tetrahydrofuran (THF) and 
substituted for the chlorine of 4-vinylbenzyl chloride, 3, to afford compound 4. Crude 
compound 1 underwent a CuAAC reaction with pure compound 4 to yield SAcGal. 
Based on 1H NMR spectroscopy, SAcGal was pure after purification using a simple silica 
plug (Figure 2.2). IR spectroscopy showed no peak at ~2095 cm-1 indicating that there 
was no free azide remaining. The first step in the synthesis of SAcGal had a quantitative 
yield and the second step had a yield of 55%. SAcGal was stored with BHT to prevent 
auto-polymerization. The BHT inhibitor was removed using a silica plug immediately 
before polymerization. 
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Scheme 2.3. Synthesis of the monomer SAcGal, a b-D-galactose pentaacetate 
functionalized styrenic monomer. 
 
 
Figure 2.2. 1H NMR spectrum of SAcGal (400 MHz, CDCl3). 
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RAFT polymerization was selected because it enabled control over important 
glycopolymer properties including the molecular weight, dispersity, and end-groups. 
Exemplified by PAGal9 and PAGal19, where the RAFT chain transfer agent (CTA) 5 
contained an alkyne group (Scheme 2.4). Due to the nature of RAFT polymerization, the 
alkyne functionalized portion of the CTA would be incorporated into one of the 
glycopolymer terminal ends. This alkyne end-group could undergo CuAAC with the 
azide on the surface of the polymersomes to conjugate the glycopolymer to the 
polymersomes. The RAFT-mediated polymerization was initiated with 
azobisisobutyronitrile (AIBN), 6, a thermal radical initiator. All free radical 
polymerization reactions are highly sensitive to O2 (g), which can react with radicals. To 
remove oxygen, two methods were explored: Freeze-pump-thaw and bubbling N2 gas 
through the polymerization mixture. Freeze-pump-thaw yielded the most consistent 
polymerization results likely due to inconsequential changes in concentration during the 
process. When bubbling N2 gas through a polymerization mixture an ice bath is 
commonly used to reduce evaporation of the solvent, but a change in concentration and 
rate of polymerization was observed. To improve consistency freeze-pump-thaw was 
used. After degassing the polymerization mixture, it was heated at 70 ºC to initiate the 
polymerization.  
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Scheme 2.4. RAFT-mediated polymerization of SAcGal and the subsequent deprotection 
and functionalization with Rhodamine B. 
 
Similar to the initial glycopolymers PAAcGal9 and PAAcGal19, two glycopolymers with 
different lengths were synthesized (Table 2.1). Mn, DPn, and Đ of the polymers were 
determined from SEC in THF relative to polystyrene standards, where calculating DPn 
involved dividing the Mn by the molar mass of the repeat unit, 560 g/mol. End-group 
analysis by 1H NMR spectroscopy was also used to determine a DPn of the polymers. To 
determine DPn the integration value of the CH2 group next to the trithiocarbonate group 
(set to 2.0) was compared to the integration value of the saccharide’s anomeric proton 
(Figure 2.3). The short protected glycopolymer PSAcGal8 had an Mn of 4,700 g/mol, DPn 
of ~8, and Đ of 1.1 based on SEC, and an Mn of 6,700 g/mol and DPn of ~12 based on 1H 
NMR. The long protected glycopolymer PSAcGal18 had an Mn of 10,000 g/mol, DP of 
~18, and Đ of 1.1 based on SEC, and an Mn of 21,000 and DPn of ~38 based on 1H NMR. 
The low dispersities determined by SEC demonstrate that the polymerizations were well 
controlled (Figure 2.4). It is unclear whether the Mn values determined by SEC or 1H 
NMR are more representative of the true average molar mass for each polymer sample. 
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The values determined by SEC are limited by how similar the solvated conformation of 
PSAcGal is to the polystyrene calibration standards in THF. The Mn calculated using 1H 
NMR spectroscopy is limited by the accuracy of the integration values, which are highly 
dependent on the conditions and parameters used to obtain the 1H NMR spectrum and the 
subsequent data processing. The important conclusion that can be drawn based on the 
relative DPns from SEC and 1H NMR spectroscopy, is that a shorter polymer, PSAcGal8, 
and a longer polymer, PSAcGal18, were successfully synthesized. Based on thermal 
analysis of PSAcGal8, onset of decomposition temperature, To, was determined to be 315 
ºC using thermogravimetric analysis (TGA), and the glass transition temperature was 
determined to be 70 ºC using differential scanning calorimetry (DSC).  
 
Table 2.1. Summarized characterization results for short and long protected 
glycopolymer PSAcGal. Determined by a SEC, b TGA, c DSC, d 1H NMR spectroscopy. 
Polymer 
Sample 
Mn (g/mol) a DPna Đ a To (ºC) b Tg (ºC) c Mn (g/mol) d DPnd 
PSAcGal8 4,700 8 1.1 315 70 6,700 12 
PSAcGal18 10,000 18 1.1   21,000 38 
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Figure 2.3. 1H NMR spectrum (400 MHz, CDCl3) of PSAcGal8 with the reference peaks 
for end-group analysis labelled. 
 
 
Figure 2.4. SEC traces of PSAcGal8 and PSAcGal18 in THF with refractive index 
detection. 
PSAcGal18 PSAcGal8 
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The galactose functional groups on PSAcGal8 and PSAcGal18 were then deprotected, 
post-polymerization, using sodium methoxide in anhydrous methanol. 1H NMR 
spectroscopy showed the disappearance of the acetyl protecting groups at ~2 ppm, which 
indicated successful deprotection of the hydroxy groups, yielding PSGal8 and PSGal18. A 
small percentage of the exposed hydroxy groups, on each polymer PSGal8 and PSGal18, 
were then functionalized with rhodamine B using the conditions described above for 
PAGal9 and PAGal19 (Scheme 2.4). The dye labeled glycopolymers, PSGal8-Rho and 
PSGal18-Rho had broad stryenic backbone peaks in aromatic region of the 1H NMR 
spectrum, making it difficult to determine the exact number of conjugated rhodamine 
molecules.   
2.2 Azide Functionalized PBD-PEO Polymersomes 
 
The Gillies group has previously reported the preparation of azide-functionalized 
polymersomes from azide-terminated polybutadiene-b-poly(ethylene glycol) (PBD-PEG) 
block copolymers.42 As previously reported, coupling of hydroxyl-terminated PBD-PEG 
(PBD-PEG-OH) with azidoacetic acid, 7, using N,N’-dicyclohexylcarbodiimide (DCC) 
and DMAP allowed for the synthesis of PBD-PEG-N3 (Scheme 2.5). The polymersomes 
were assembled using an optimized thin-film hydration method. By varying the ratio of 
PBD-PEG-OH and PBD-PEG-N3, the density of azides on the polymersome surface 
could be tuned. The PBD-PEG-OH and PBD-PEG-N3 were weighed out in the targeted 
ratio and dissolved in CHCl3. The solvent was evaporated under a stream of nitrogen, 
then the vial was put under high-vacuum for 16 hours to yield a thin-film. The film was 
hydrated with Milli-Q water at 46 °C overnight, then stirred rapidly at 46 °C for 16 hours 
to afford polymersomes. The initial compositions tested were 10% and 100% PBD-PEG-
N3, with the remainder being PBD-PEG-OH. Polymersomes were imaged using confocal 
laser scanning microscopy (CLSM) by incorporating nile red, a fluorescent probe, into 
the hydrophobic membrane of the polymersome. This was accomplished by the addition 
of 0.1 weight percent (wt%) of nile red to the polymer in CHCl3 during the polymer film 
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preparation. CLSM images of the PBD-PEG assemblies confirmed the vesicle 
morphology (Figure 2.5 (a)). The polymersomes were approximately 3-5 µm in size.  
 
Scheme 2.5. Synthesis of azide functionalized PBD-PEG (PBD-PEG-N3). 
 
  
Figure 2.5. CLSM images of 100% PBD-PEG-N3 polymersomes: a) loaded with nile red 
and (b) with rhodamine functionalized glycopolymer, PAGal19-Rho, conjugated to the 
surface. 
 
Next, polymersomes containing 10% and 100% PBD-PEG-N3 were assembled without 
nile red. These assemblies were reacted with rhodamine functionalized polymers using 
b O
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110 90
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30 
 
CuAAC by adding CuSO4, (+)-sodium L-ascorbate, bathophenanthrolinedisulfonic acid 
disodium salt hydrate (BPS), and either PAGal9-Rho or PAGal19-Rho to the 
polymersome solution (Scheme 2.6). After the CuAAC reaction, unreacted 
glycopolymer, CuSO4, (+)-sodium L-ascorbate, and DPS were removed by dialysis 
against water using a 50,000 MWCO membrane. A control experiment, where no CuSO4 
was added to the reaction mixture, was conducted to confirm that any unreacted dyed 
glycopolymer was removed using dialysis. The glycopolymer coated assemblies were 
imaged using CLSM. Images indicated that the vesicle morphology was retained post-
functionalization with PAGal9-Rho or PAGal19-Rho at 10% and 100% surface 
functionalization densities (Figure 2.5 (b)). PSGal-Rho polymers were conjugated to 
PBD-PEG-N3 polymersomes using the same methods above. CLSM images similarly 
indicate that vesicle morphology was retained post-functionalized with PSGal8-Rho at 
10% and 100% surface functionalization densities (Figure 2.6). PSGal18-Rho 
functionalized assemblies were not able to be successfully imaged at either surface 
density. 
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Scheme 2.6. Preparation of PAGal-Rho-functionalized PBD-PEG polymersomes. 
 
  
Figure 2.6. CLSM image of (a) 10% PBD-PEG-N3 and (b) 100% PBD-PEG-N3 
polymersomes conjugated with PSGal9-Rho. 
b) 
10 µm 10 µm 
a) 
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2.3 Quantification of CuAAC with Azide Functionalized 
PBD-PEO Polymersomes 
 
PBD-PEG polymersomes functionalized with dye labelled glycopolymers were used to 
determine the percent of surface functionalization for PAGal9-Rho, PAGal19-Rho, and 
PSGal8-Rho. Fluorescence spectroscopy was used to determine the concentration of 
rhodamine labelled glycopolymer present after the reaction and purification of the 
polymersomes by dialysis. This was determined by comparing the fluorescence counts of 
the decorated polymersomes in dimethyl sulfoxide (DMSO) to the fluorescence counts of 
a calibration curve for the corresponding dye labelled polymer PAGal9-Rho, PAGal19-
Rho, and PSGal8-Rho in DMSO. A calibration curve was created for each PAGal9-Rho, 
PAGal19-Rho, and PSGal8-Rho because they had different percentages of dye 
functionalization. The results indicated that polymersome samples prepared from 10 wt% 
of PBD-PEG-N3 had a higher degree of N3 groups functionalized with dye labelled 
glycopolymers PAGal9-Rho and PAGal19-Rho (Table 2.2). The lower degree of N3 
groups functionalized on the 100 wt% of PBD-PEG-N3 polymersome samples may be 
due to the steric hindrance that is associated with functionalizing every N3 group. 
Glycopolymer length appeared to have no significant effect on the percentage of 
functionalized azide groups. It should be noted that 100% functionalization would mean 
that 50% of all present azide groups had reacted. The reference of 50% is selected 
because it is assumed that 50% of the azide groups would be on the surface of the interior 
cavity of the polymersome and unavailable to react with the glycopolymer. A previous 
study on the amount of azide groups available to react on the surface of PBD-PEG 
polymersomes indicated that the above assumption is reasonable.39,42  
 
33 
 
Table 2.2. Table summarizing the percentage of functionalized azide groups relative to 
the total number of available azide groups. 
 10% of PBD-PEG-N3 (%) 100% of PBD-PEG-N3 (%) 
PAGal9-Rho 82 74 
PAGal19-Rho 90 70 
PSGal8-Rho  89 
 
2.4 Difficulties in the reproducibility of polymersome 
preparation 
 
At this stage in the project, difficulties arose with the reproducibility of the self-
assembled polymersomes. The irreproducible nature of the polymersome formation may 
be attributed to the potential crosslinking of free double bonds in the PBD block of the 
PBD-PEG block copolymers. The recent 1H NMR spectrum of the PBD-PEG block 
copolymer appeared similar to the spectrum recorded a year earlier. A large decrease in 
the integration of the vinyl peaks at around 5.4 ppm would have been a clear indication of 
crosslinking. However small decreases, or a small amount of crosslinking, couldn’t be 
accurately assessed due to the broad nature of polymer 1H NMR peaks. Minor changes in 
the chemical properties of the polymer sample, even by small amounts of crosslinking or 
oxidation, could disrupt the self-assembly of polymersomes. It should be noted that 
small, unidentifiable changes to the self-assembly technique, could also be responsible 
for the change in observed morphology. Polymer Source, the polymer provider, 
discontinued the exact polymer sample the Gillies group had previously used, so a fresh 
batch of polymer could not be ordered. Ultimately, due to the issues with reproducibility 
and availability, a more robust system for forming polymersomes using a polymer we 
could make in the lab was selected for future studies.  
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2.5 Azide Functionalized PEG-PEtG-PEG Polymersomes 
 
Poly(ethyl glyoxylate) (PEtG) is a hydrophobic polymer that has been shown to self-
assemble when coupled with PEG. The Gillies group has previously shown that MeO-
PEG-PEtG-PEG-OMe triblock polymers self-assembled into vesicle morphologies 
when the length of each terminal PEG was 750 g/mol and the PEtG block was ~63,000  
g/mol.45 In order to produce functionalizable polymersomes of PEtG and PEG, azides 
were incorporated onto the triblock termini (N3-PEG-PEtGUV-PEG-N3). To vary the 
degree of surface functionalization, a similar triblock copolymer with methyl ether 
terminal groups was also prepared (MeO-PEG-PEtGUV-PEG-OMe) (Figure 2.7).  
 
 
Figure 2.7. Structures of the target triblock copolymers (a) MeO-PEG-PEtGUV-PEG-
OMe (550) and (b) N3-PEG-PEtGUV-PEG-N3 (600) and N3-PEG-PEtGUV-PEG-N3 
(1000). 
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The first step in the synthesis of the triblocks was making the PEG portions. Compound 8 
(Mn = 550 g/mol) and 11 (Mn = 600 g/mol) and 12 (Mn = 1,000 g/mol), were reacted with 
mesyl chloride, 9, to convert the alcohol into a good leaving group (Scheme 2.7). The 
mesylated PEGs, 10, 13, and 14, were then reacted with sodium azide to afford the 
corresponding azide-terminated PEGs MeO-PEG-N3 (550), N3-PEG-N3 (600), and N3-
PEG-N3 (1000). 1H NMR spectroscopy indicated the successful substitution of the mesyl 
group with an azide group in all cases. The substitution was indicated by the 
disappearance of the methyl peak of the mesyl group at 3.1 ppm. In addition, IR 
spectroscopy confirmed the presence of an azide peak in MeO-PEG-N3 (550), N3-PEG-
N3 (600), and N3-PEG-N3 (1000) at ~2098 cm-1. Two PEG di-azide compounds of 
different lengths were made to test the effect of PEG length on self-assembly. Previous 
examples of MeO-PEG-PEtG-PEG-OMe that could form polymersomes used PEG 
with an Mn of 750 g/mol, but a diol form with a similar Mn was not commercially 
available. 
 
Scheme 2.7. Synthesis of (a) mono-azide terminated PEG, MeO-PEG-N3, and (b) di-
azide terminated PEG, N3-PEG-N3. 
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The PEtG portion of the triblock, PEtGUV (Scheme 2.8) with alkyne terminal groups was 
previously prepared and had an Mn of 72,000 and Đ of 1.9. It is important to note that the 
end-cap used is reactive with UV light, and this could be taken advantage of to trigger 
polymer degradation. However, it was not the goal of the current work to take advantage 
of the degradable properties. CuAAC was used to couple the PEGs to the PEtGUV 
(Scheme 2.8). For the reaction between PEtG and both N3-PEG-N3 compounds, a molar 
excess of up to 100 times was used. It would have required a multi-step synthesis to form 
a unilaterally functionalized PEG moiety. Instead, by using a large excess of N3-PEG-N3, 
a statistical mixture favouring the exclusive reaction of N3-PEG-N3 and PEtGUV alkyne 
was used. This approach minimized the reaction of a single N3-PEG-N3 with two 
different alkyne terminated PEtGUV polymers, which prevented the potential formation 
of a copolymer containing five or more blocks. The resulting triblock polymers were 
characterized using 1H NMR spectroscopy, Fourier-transform infrared spectroscopy (FT-
IR), and SEC. 1H NMR spectroscopy indicated that the coupling of all three PEG 
compounds to PEtGUV was successful, based on the appearance of the expected PEG 
peaks at around 3.64 ppm (Figure 2.8). FT-IR did not show any sharp peaks at ~2098 cm-
1, which are expected if there is unreacted PEG azide in the sample (Figure 2.9). 
However, the lack of an azide related peak could have been due to the relatively small 
amount of azide compared to the amount of polymer, thus, SEC was used to confirm that 
only trace amounts of PEG were present and the respective peaks in the 1H NMR 
spectrum are not from excess unreacted PEG (Figure 2.10). It was concluded that the 
CuAAC reaction and subsequent purification was successful. 
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Scheme 2.8. Synthesis of MeO-PEG-PEtGUV-PEG-OMe (550) and (b) N3-PEG-
PEtGUV-PEG-N3 (600). 
OO
O OO O
O O
NO2 NO2
O
N
H
O
N
H
O
n-1
O N3
m
O
n-1
N3 N3100 equiv. xs. CuSO4, NaASC, DMF, 50 ˚C, o/n
CuSO4, NaASC, DMF, 50 ˚C, o/n
OO
O OO O
O O
NO2 NO2
O
N
H
O
N
H
m
N
N NO n-1
O N
NN O n-1
O
OO
O OO O
O O
NO2 NO2
O
N
H
O
N
H
m
N
N NO n-1
N3 N
NN O n-1
N3
N3-PEG-PEtGUV-PEG-N3 (600) (m = 530, n = 14)
MeO-PEG-PEtGUV-PEG-OMe (550) (m = 530, n = 13)
PEtGUV
N3-PEG-N3 (600)
MeO-PEG-N3 (550)
N3-PEG-N3 (1000)
N3-PEG-PEtGUV-PEG-N3 (1000) (m = 530, n = 23)
38 
 
 
Figure 2.8. 1H NMR spectrum (400 MHz, CDCl3) of MeO-PEG-PEtGUV-PEG-MeO 
(550). 
 
Figure 2.9. FT-IR spectrum of MeO-PEG-PEtGUV-PEG-MeO (550). 
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Figure 2.10. Overlay of the SEC traces for (a) MeO-PEG-PEtGUV-PEG-MeO (550) 
and (b) MeO-PEG-N3. 
Various ratios of polymers MeO-PEG-PEtGUV-PEG-MeO (550) and N3-PEG-PEtGUV-
PEG-N3 (600) were self-assembled to alter the surface azide density. In order to visualize 
the resulting assemblies, they were loaded with perylene, a hydrophobic fluorescent 
probe that excites at 410 nm. This probe was selected because the excitation and emission 
curves do not overlap with the respective curves of the rhodamine labelled 
glycopolymers, PSGal-Rho, allowing for direct quantification by fluorescence 
microscopy after imaging with CLSM. Unfortunately, the self-assembly of MeO-PEG-
PEtGUV-PEG-MeO (550), N3-PEG-PEtGUV-PEG-N3 (600), or PEG-PEtGUV-PEG-N3 
(1000) at any ratio (10%, 20%, or 50%) initially lead to small particles could be imaged 
by CLSM, but no distinguishable membrane structure typical of vesicle morphology was 
observed (Figure 2.11). Transmission electron microscopy (TEM) is commonly used to 
visualize the morphology of smaller particles, but unfortunately the instrument was 
unavailable for an extended period of time, which prevented analysis by TEM. The self-
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assembly of samples containing exclusively polymer MeO-PEG-PEtGUV-PEG-MeO 
(550), N3-PEG-PEtGUV-PEG-N3 (600), or PEG-PEtGUV-PEG-N3 (1000) were tested to 
determine if large polymersomes could be formed by a single triblock, rather than a 
mixture. The results indicated that small particles formed for all three triblock samples. 
The z-average diameter of the assemblies MeO-PEG-PEtGUV-PEG-MeO (550) and N3-
PEG-PEtGUV-PEG-N3 (600) were determined to be 182 nm with a PDI of 0.06 and 
155.9 with a PDI of 0.143 by DLS. The PDI for a sample to be considered monodisperse 
must be less than 0.2. Thus, the assemblies of MeO-PEG-PEtGUV-PEG-MeO (550) and 
N3-PEG-PEtGUV-PEG-N3 (600) are both monodisperse and could be useful for 
functionalization depending on the morphology determined by TEM imaging in the 
future.  
 
Figure 2.11. CLSM images of the PEG-PEtGUV-PEG-N3 (1000) suspension, showing 
that small particles were obtained. 
 
10 µm 
41 
 
A MeO-PEG-PEtGThermo-PEG-OMe triblock polymer containing a PEtGThermo block 
with an Mn of 63,000 g/mol and PEG with an Mn of 750 g/mol, and a thermos-responsive 
end-cap (Figure 2.12) was shown by the Gillies group to form large polymersomes that 
could be visualized by CLSM. To take advantage of this polymersome forming triblock 
polymer and form large easily visualized polymersomes coated with azide groups, MeO-
PEG-PEtGThermo-PEG-OMe was mixed with PEG-PEtGUV-PEG-N3 (1000). The ratios 
selected were 10%, 30%, and 50% PEG-PEtGUV-PEG-N3 (1000) to MeO-PEG-
PEtGThermo-PEG-OMe. Preliminary CLSM images of the mixed suspensions indicated 
larger vesicle and smaller particles morphologies were present (Figure 2.13). Similar 
mixed morphologies were observed for all polymer ratios. By optimizing both the mixing 
ratios and methods used to form the assemblies, mixing MeO-PEG-PEtGThermo-PEG-
OMe and PEG-PEtGUV-PEG-N3 (1000) may present a viable route to achieving 
reproducible and functionalizable polymersomes. 
 
Figure 2.12. Chemical structure of MeO-PEG-PEtGThermo-PEG-OMe. 
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Figure 2.13. (a) Large vesicle morphology and (b) small particles observed within the 
same 10 wt% N3-PEG-PEtGUV-PEG-N3 (1000) 90 wt% MeO-PEG-PEtGThermo-PEG-
OMe (750) nanoparticle suspension. 
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Chapter 3  
3 Experimental 
 
General Procedures and Methods. Compounds 146, 2, 5 ,744, 447, 1048, 1348 and 1448 
were prepared as previously reported. PEtGUV had an Mn = 54,000 g/mol and Đ = 2.2 by 
SEC in THF. PEtGThermo had an Mn = 63,000 g/mol and Đ = 2.0 by SEC in THF. DIPEA 
and dichloromethane were distilled from calcium hydride before use. Anhydrous THF 
was obtained from a solvent purification system using aluminum oxide columns. All 
other solvents were purchased from Caledon Labs. All the other chemicals were reagent 
grade and used without further purification. NMR spectra were obtained on 400 or 600 
MHz Varian Inova spectrometers (Agilent Tech., Santa Clara, CA). NMR chemical shifts 
(δ) are reported in ppm and are calibrated against the residual solvent signals of CDCl3 (δ 
7.27; 77.4), CD3CN (δ 1.94; 116.4), d6-DMSO (δ 2.50; 40.8), or D2O (δ 4.75). Size 
exclusion chromatography (SEC) was performed using a Viscotek GPC Max VE2001 
solvent module (Agilent Tech.), a Viscotek VE3580 RI detector operating at 30 °C, two 
Agilent Polypore (300 × 7.5 mm) columns connected, and a Polypore guard column (50 
× 7.5 mm). THF (glass distilled grade) was used as the eluent. A calibration curve was 
obtained from polystyrene standards. Dialysis was performed using Spectra/Por 6 
regenerated cellulose membranes from Spectrum Laboratories (Rancho Dominguez, CA, 
USA). Fourier-transform infrared (FT-IR) spectra were obtained in attenuated total 
reflectance (ATR) mode using a PerkinElmer UATR Spectrum Two, with bulk material 
deposited on the diamond. Ultrapure water was obtained from a Barnstead EASYpure II 
system. The Z-average diameters of the polymersome assemblies were measured by 
dynamic light scattering (DLS) using a Zetasizer Nano Series ZS instrument from 
Malvern Instruments, at room temperature (25 ºC) in a 1 cm path length low volume (1 
mL) polystyrene cuvette at a polymer concentration of 0.8 mg/mL. Fluorescence spectra 
were obtained using a QM-SE spectrometer from Photon Technology International (PTI). 
Thermogravimetric analyses (TGA) were performed on a TGA Q50 from TA 
Instruments. The heating rate was 10。C /min between 15-1000 ºC under N2 (g). 
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Differential scanning calorimetry (DSC) was performed using a Q2000 from TA 
Instruments. The heating/cooling rate was 10 ºC/min from -70 to +150 ºC. Glass 
transition temperatures (Tg) were obtained from the third heating cycle. 
Synthesis of SAcGal. 1-O-2-Azidoethyl-β-D-galactose tetraacetate46 (19 g, 46 mmol, 1.0 
equiv.) was dissolved in minimal dimethylformamide (DMF) with stirring. Sequentially, 
CuSO4 (0.90 g, 4.6 mmol, 0.10 equiv.), (+)-Sodium L-ascorbate (2.7 g, 4.6 mmol, 0.10 
equiv.), and compound 4 (9.4 g, 55 mmol, 1.2 equiv.) dissolved in minimal DMF, were 
added to the flask. 450 mL of 4:1 DMF:water was added to the mixture and it was heated 
with rapid stirring at 50 °C overnight. The reaction mixture was concentrated in vacuo 
and the crude product dissolved in CH2Cl2 (500 mL), washed with water, brine (300 mL 
each). The organic layer was dried with MgSO4, filtered and concentrated. The crude 
mixture was precipitated twice from minimal THF into cold pentane and residual solvent 
removed under high vacuum to yield SAcGal (14.5 g, 55%). 1 g of BHT in 20 mL of 
dichloromethane was added to the SAcGal and the solution was stored in a -20 ºC freezer 
to prevent polymerization. 1H NMR (400 MHz, CD3CN): δppm 7.52 (s, 1H), 7.24 (d, 2H, J 
= 8.0 Hz), 7.13 (d, 2H, J = 8.0 Hz), 6.56 (dd, 1H, J = 12.0, 16.0 Hz), 5.60 (d, 1H, J = 16.0 
Hz), 5.12 (d, 1H, J = 4 Hz), 5.05 (d, 1H, J = 12.0 Hz), 4.83-4.75 (m, 2H), 4.40-4.30 (m, 
8H), 3.99-3.91 (m, 2H), 1.70 (s, 6H), 1.87 (s, 3H), 1.79 (s, 3H), 1.71 (s, 6H). FT-IR (cm-
1, film from CH2Cl2): 2867, 1743, 1368, 1218, and 1046 cm-1. 
Synthesis of PSAcGal8 and the general procedure for the polymerization of SAcGal. 
Before use, SAcGal containing BHT was dissolved in CH2Cl2 and loaded onto a silica 
plug. BHT was eluted with CH2Cl2 and discarded. The monomer was then eluted with 
100% methanol. The methanol was removed in vacuo and the purified SAcGal (1.2 g, 2.2 
mmol, 13 equiv.), CTA (compound 5) (50 mg, 170 µmol, 1.0 equiv.), and AIBN, 6, (9.4 
mg, 57 µmol, 0.33 equiv.) were deposited in a reaction tube and dissolved in acetonitrile 
(1 mL). The polymerization mixture was subjected to four cycles of freeze-pump-thaw. A 
freeze-pump-thaw cycle began with freezing the polymerization mixture using liquid 
nitrogen under a positive pressure of N2 (g). Once the sample was frozen, the flask was 
placed under active high vacuum for 5 min, with the flask remaining in liquid nitrogen. 
The flask was removed from the liquid nitrogen and placed under static vacuum, until the 
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sample was thawed. The sample would then be re-frozen, and the cycle repeated the 
desired number of times. After being placed under positive pressure of N2 (g), the mixture 
was heated to 75 °C and stirred rapidly for 36 h. The polymerization mixture was allowed 
to cool to room temperature and concentrated. The crude polymer was dissolved in DMF 
(2 mL) and dialyzed against 1 L of DMF using a 2,000 g/mol MWCO membrane for 18 
h. The solution was concentrated yielding PSAcGal8 (910 mg, 76%). 1H NMR (400 
MHz, CDCl3): δppm 7.65 (br s, 1H), 7.23-6.30 (br, 4H), 5.38 (br s, 1H), 5.19 (br, 1H), 5.00 
(br s, 1H), 4.76-4.35(br, 7H), 4.26 (s, 1H), 4.26 (m, 2H), 3.94 (br s, 2H), 2.15-1.96 (m, 
13H), 1.72-1.30 (br, 4H), 0.89 (br s, 1H). SEC: Mn = 4,700 g/mol, Mw = 5,300 g/mol, Đ 
= 1.1.  
Synthesis of PSAcGal18. The polymer was synthesized by the same procedure described 
for PSAcGal8 except for the following changes. Purified SAcGal (1.2 g, 2.2 mmol, 45 
equiv.), CTA (compound 5) (14 mg, 48 µmol, 1.0 equiv.), and AIBN (2.6 mg, 16 µmol, 
0.33 equiv.) were deposited in a reaction tube and dissolved in acetonitrile (1 mL). The 
polymerization mixture was heated at 75 ºC with rapid stirring for 6 days. Purification 
yielded PSAcGal18 (690 mg, 57%). 1H NMR (400 MHz, CDCl3): δppm  7.65 (br s, 1H), 
7.15-6.15 (br, 4H), 5.37 (br s, 1H), 5.15(br, 1H), 4.98 (br s, 1H), 4.67-4.28(br, 7H), 4.23 
(s, 1H), 4.12 (m, 2H), 3.92 (br s, 2H), 2.18-1.77 (m, 13H), 1.75-1.09 (br, 4H), 1.25 (m, 
4H), 0.83 (br s, 1H). SEC: Mn = 10,000 g/mol, Mw = 11,000 g/mol, Đ = 1.1. 
Synthesis of PSGal8 and the general procedure for the deprotection of PSAcGal. 
PSAcGal8 (350 mg, 75 µmol, 1.0 equiv.) was deposited in a flame dried round bottom 
flask and dissolved in 10 mL of anhydrous methanol. The reaction flask was placed in a 0 
ºC ice bath and sodium methoxide (200 mg, 3.7 mmol, 50 equiv.) solid was added to the 
flask slowly. The flask was removed from the ice bath after 30 min and allowed to warm 
to room temperature. The reaction mixture was stirred for 16 h and checked by thin layer 
chromatography (TLC) (100% Methanol) to confirm complete deprotection. The pH of 
the resulting solution was adjusted to 7 using NH4Cl and concentrated. The resulting 
crude compound was dissolved in 2 mL of DI water and purified by dialysis against DI 
water using a 2,000 MWCO membrane. The water was removed using a freeze dryer 
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affording PSGal8 (190 mg, 72%).  1H NMR (400 MHz, D2O): δppm 7.91-7.32 (br), 7.10-
5.83 (br), 4.25-2.91 (br), 2.89-2.62 (br), 1.55-1.37 (br), 1.24-1.05 (br), 0.84-0.20 (br).  
Synthesis of PSGal18. The polymer was deprotected by the same procedure described for 
PAcGal8 except for the following amounts were used. PSAcGal18 (500 mg, 50 µmol, 1.0 
equiv.) and sodium methoxide (200 mg, 3.7 mmol, 74 equiv.). Purification yielded 
PSGal18 (230 mg, 63%).  1H NMR (600 MHz, D2O): δppm 8.27-7.74 (br), 7.43-6.02 (br), 
4.75-3.14 (br), 2.05-0.45 (br). 
Synthesis of PSGal8-Rho and the general procedure for the Rhodamine labelling 
PSGal. PSGal8 (150 mg, 48 µmol, 1.0 equiv.) was dissolved in minimal DMF. EDC.HCl 
(16 mg, 100 µmol 2.1 equiv.), DPTS (3.6 mg, 17 µmol, 0.35 equiv.), and DMAP (2 mg, 
20 µmol, 0.4 equiv.) were added to the stirring solution simultaneously. Rhodamine B 
(3.2 mg, 6.7 µmol, 0.14 equiv.) was then added to the solution slowly. The solution was 
stirred overnight. The crude reaction mixture was dialyzed against 1L of DI water using 
2,000 MWCO dialysis tubing for 48 h, with the dialysate being changed twice. The 
polymer solution was concentrated yielding PSGal8-Rho. The polymer was used as-is 
and was not fully characterized. lmax Absorbance = 510 nm. lmax Emission = 584 nm.  
Extinction Coefficient = 618,000 mL/mg at 584 nm. 
Synthesis of PSGal18-Rho. The polymer was labelled by the same procedure described 
for PAcGal8-Rho except for the following amounts were used. PSGal18 (100 mg, 10 
µmol, 1.0 equiv.), EDC.HCl (3.6 mg, 23 µmol, 2.3 equiv.), DPTS (0.82 mg, 3.8 µmol, 
0.38 equiv.), DMAP (0.5 mg, 4 µmol, 0.40 equiv.), and Rhodamine B (3.2 mg, 1.5 µmol, 
0.15 equiv.) The polymer solution was concentrated yielding PSGal18-Rhodamine. The 
polymer was used as-is and was not fully characterized. lmax Absorbance = 510 nm. lmax 
Emission = 574 nm. Extinction Coefficient = 813,000 mL/mg at 574 nm.  
Synthesis of MeO-PEG-N3 (550) and the general procedure for the synthesis of 
PEG-N3 compounds. Compound 1048 (20 g, 33 mmol, 1.0 equiv.) was dissolved in 
DMF. Sodium azide (21 g, 320 mmol, 9.7 equiv.) was added with stirring. An air 
condenser was added to the flask, which was then heated to 80 ºC and stirred overnight. 
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The DMF was removed in vacuo and the crude product was dissolved in 500 mL of 
dichloromethane, filtered, and then washed with DI water (30 mL x2). The organic phase 
was concentrated, then water was removed using a toluene wash (3 x 200 mL). The 
product was dissolved in minimal dichloromethane and precipitated into cold diethyl 
ether. The ether was decanted, the precipitate collected, and dried on high vacuum to 
yield MeO-PEG-N3 (550) (14 g, 75%). 1H NMR (400 MHz, CDCl3): δppm 3.68-3.62 (m, 
49H), 3.56-3.52 (m, 2H), 3.40-3.35 (m, 5H). FT-IR: 2865, 2103, 1456, 1348, 1293, 1249, 
1100 cm-1. SEC: Mn = 380 g/mol, Mw = 490 g/mol, Đ = 1.3. 
Synthesis of N3-PEG-N3 (600). The azide was substituted by the same procedure 
described for MeO-PEG-N3 (550) except for the following amounts were used. 
Compound 1348 (18 g, 25 mmol, 1.0 equiv.) and sodium azide (18 g, 280 mmol, 11 
equiv.). Purification yielded N3-PEG-N3 (600) (14 g, 75%). 1H NMR (400 MHz, CDCl3): 
δppm 3.66-3.59 (m, 57H), 3.36 (t, J = 12 Hz, 4H). FT-IR: 2865, 2098, 1456, 1347, 1287, 
1249, 1100 cm-1. SEC: Mn = 470 g/mol, Mw = 571 g/mol, Đ = 1.2. 
Synthesis of N3-PEG-N3 (1000). The azide was substituted by the same procedure 
described for MeO-PEG-N3 (550) except for the following amounts were used. 
Compound 1448 (20 g, 20 mmol, 1.0 equiv.) and sodium azide (11 g, 170 mmol, 8.5 
equiv.). Purification yielded N3-PEG-N3 (1000) (14 g, 75%). 1H NMR (600 MHz, 
CDCl3): δppm 3.59-3.51 (m, 91H), 3.29 (t, J = 6 Hz, 4H). FT-IR: 2865, 2098, 1456, 1347, 
1287, 1249, 1100 cm-1. SEC: Mn = 1,400 g/mol, Mw = 1,500 g/mol, Đ = 1.1. 
Synthesis of MeO-PEG-PEtGUV-PEG-OMe and the general procedure for the 
coupling of PEG to PEtG. MeO-PEG-N3 (550) (30 mg, 52 µmol, 19 equiv.) was 
dissolved in 2 mL of DMF. 10 mg of CuSO4, 10 mg of (+)-sodium L-ascorbate, and 
PEtGUV (150 mg, 2.8 µmol, 1.0 equiv.) were subsequently added to the solution. The 
solution was heated with stirring for 18 h at 40 ºC. The resulting solution was dialyzed 
against 1L DI water, using a 3,500 g/mol MWCO membrane, overnight. The water was 
removed using a freeze dryer to yield MeO-PEG-PEtG-PEG-OMe (120 mg, 78%). 1H 
NMR (400 MHz, CDCl3): δppm 5.70-5.52 (m, 833H), 4.21 (br s, 1705), 3.67-3.52 (br, 
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100H), 1.30-1.27 (m, 2591H). FT-IR: 2984, 2917, 2850, 1750, 1215, 1013, and 957cm-1. 
SEC: Mn = 65,000 g/mol, Mw = 271,000 g/mol, Đ = 4.2. 
Synthesis of N3-PEG-PEtGUV-PEG-N3 (600). N3-PEG-N3 (600) was coupled to 
PEtGUV by the same procedure described for MeO-PEG-PEtGUV-PEG-OMe except for 
the following amounts were used. N3-PEG-N3 (600) (120 mg, 190 µmol, 68 equiv.), 10 
mg of CuSO4, 10 mg of (+)-sodium L-ascorbate, and PEtGUV (150 mg, 2.8 µmol, 1.0 
equiv.). Purification yielded N3-PEG-PEtGUV-PEG-N3 (600) (120 mg, 78%). 1H NMR 
(600 MHz, CDCl3): δppm 5.73-5.46 (m, 868H), 4.22 (br s, 1757), 3.67-3.54 (br, 109H), 
1.30-1.27 (m, 2788H). FT-IR: 2984, 2917, 2850, 1750, 1215, 1013, and 957cm-1. SEC: 
Mn = 60,000 g/mol, Mw = 162,000 g/mol, Đ = 2.7. 
Synthesis of N3-PEG-PEtGUV-PEG-N3 (1000). N3-PEG-N3 (1000) was coupled to 
PEtGUV by the same procedure described for MeO-PEG-PEtGUV-PEG-OMe except for 
the following amounts were used. N3-PEG-N3 (1000) (300 mg, 270 µmol, 96 equiv.), 10 
mg of CuSO4, 10 mg of (+)-sodium L-ascorbate, and PEtGUV (150 mg, 2.8 µmol, 1.0 
equiv.). Purification yielded N3-PEG-PEtGUV-PEG-N3 (1000) (120 mg, 78%). 1H NMR 
(600 MHz, CDCl3): δppm 5.71-5.46 (m, 965H), 4.22 (br s, 1952H), 3.66-3.56 (br, 184H), 
1.30-1.27 (m, 3028H). FT-IR: 2984, 2917, 2850, 1750, 1215, 1013, and 957cm-1. SEC: 
Mn = 108,000 g/mol, Mw = 492,000 g/mol, Đ = 4.6. 
PBD-PEG Nanoparticle Preparation. The procedure was adapted from a previously 
reported method.42 In a 3-mL dram vial, 5.0 mg of polymer (PBD-PEG-OH, PBD-PEG-
N3, or a mixture) was mixed with 50 µg of the hydrophobic dye Nile Red in 0.5 mL of 
chloroform and then the solvent was evaporated under a stream of nitrogen gas. The 
resulting thin film was further dried under high vacuum overnight to remove traces of 
solvent. The thin film was then hydrated overnight with 0.5 mL of filtered Ultrapure 
water and kept at 46 °C. A stir bar was then added to the vial and it was rapidly stirred 
(1000 rpm or greater) overnight. The vesicles were then imaged by confocal laser 
scanning microscopy (see below).  
PEG-PEtG-PEG Nanoparticle Preparation. 8 µL of 0.1 mg/mL perylene in 
dichloromethane solution was added to a dram vial and the solvent was evaporated using 
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a stream of nitrogen gas. 100 µL of 8 mg/mL triblock in THF (MeO-PEG-PEtG-PEG-
OMe or N3-PEG-PEtG-PEG-N3, or a mixture of both) triblock in THF was added to the 
vial along with a small magnetic stir bar. The solution was stirred for 5 min, then at a stir 
rate of 400 rpm, 0.9 mL of DI water was added dropwise (~1 drop per second). After 
stirring for another 20 min, the suspension was transferred to a 50,000 MWCO dialysis 
membrane and dialyzed against 1L of DI water to remove the THF. The resulting 
suspension was stored in a 4 ºC fridge. 
Confocal Laser Scanning Microscopy (CLSM). 10 µL of the aqueous suspension of 
polymersomes was dropped onto a glass slide, a glass coverslip was placed on top, and 
the outside edges of the coverslip were sealed with nail polish. The slides were stored at 4 
ºC for 2 h prior to imaging. Images were obtained using a confocal laser scanning 
microscope (LSM 510, Carl Zeiss Inc.) using a 63X (Nanoparticles suspensions which 
contained Nile Red) and 100X (Nanoparticles suspensions which contained PAGal-
Rhodamine, PSGal-Rhodamine, or perylene) oil immersion objective, and an excitation 
wavelength of 543 nm (Nanoparticles suspensions which contained Nile Red, PAGal-
Rhodamine, or PSGal-Rhodamine) and 405 nm (Nanoparticles suspensions which 
contained perylene). 
Fluorescence Calibration Curves. PAGal-Rhodamine and PSGal-Rhodamine were 
dissolved in dimethyl sulfoxide (DMSO) to achieve a concentration of 0.25 mg/mL. The 
solution was then diluted with DMSO to obtain measurements at a minimum of four 
different concentrations ranging from 0.05 mg/mL to 0.25 mg/mL. Acquisition settings 
were as follows: Excitation @ 562 nm, Emission from 565 to 610 nm, Length = 45 nm, 
Step Size = 0.25 nm, Integration = 1 s, Averages = 1. The 3 mL glass cuvette was rinsed 
3 times with 1.5 mL of DMSO between samples. All measurements were taken in 
triplicate and then averaged to obtain the values used for the calibration curve.  
Fluorescence Spectroscopy to Quantify Azide-Alkyne Click. Each nanoparticle 
suspension had the water removed using a freeze dryer to yield a powdered sample. The 
sample was then dissolved in 1 mL of DMSO. The fluorescence counts were then 
measured using the same parameters used to create the calibration curves. All 
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measurements were taken in triplicate and then averaged to obtain the concentration 
values. 
Method to Calculate the Percentage of Functionalized Azide Groups. To calculate the 
percentage of functionalized N3 groups, first the theoretical yield of the click reaction was 
determined. The mass of the PBD-PEG was adjusted for the relative amount of azide 
density, where polymer samples containing 10% PBD-PEG-N3 were multiplied by 0.1 
and 100% azide functionalized PBD-PEG-N3 were multiplied by 1. The mass was then 
adjusted for the amount of available azide due to the nature of vesicles. PBD-PEG-N3 
will be on the inside of the polymersome, with the expected ratio being 50:50 inside: 
outside. To make the appropriate adjustment, the mass was multiplied by 0.5. The moles 
of azide were calculated by dividing the mass of available azide by the molar mass of the 
PBD-PEG-N3 which was approximately 10000 g/mol. The moles of azide were assumed 
to be equal to the moles of alkyne functionalized glycopolymer as they react in a 1:1 
ratio. Multipling the moles of alkyne functionalized glycopolymer by the molar mass of 
the respective polymer, short glycopolymer = 2,400 g/mol or long glycopolymer = 5,200 
g/mol, the expected or theoretical mass of dyed glycopolymer was determined. The 
experimental yield or mass of dyed glycopolymer, determined using the calibration 
curve, was divided by the theoretical yield to determine the percent functionalization of 
the azide groups on the vesicles.   
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Chapter 4  
4 Conclusions and Future Work 
 
The work in this thesis provided progress towards producing glycopolymer 
functionalized polymersomes and quantifying their degree of functionalization. It was 
shown that the degree of PBD-PEG polymersome surface functionalization could be 
quantified by measuring the fluorescence of a glycopolymer, PAGal, labelled with 
rhodamine B. Difficulty with the synthesis of the PAAcGal led to the development and 
synthesis of a second glycopolymer with pendent b-D-galactose moieties, PSAcGal. 
PSAcGal having two different DPn values were synthesized, deprotected, and labelled 
with rhodamine B. 
The shorter dye-labelled glycopolymer was conjugated to the surface of PBD-PEG 
polymersomes, yielding similar surface functionalization as the previous glycopolymer, 
PAGal. The relative amount of functionalization that could be achieved when the 
polymersomes had 10% compared to 100% of the surface containing an azide group, was 
determined for each length of dye-labelled glycopolymer. The results indicated that the 
length of the glycopolymer did not significantly affect the yield of the CuAAC reaction, 
but that a higher yield was obtained at lower azide densities. It is speculated that the high 
degree of steric hindrance associated with functionalizing every azide group on the 
surface of the polymersome decreased CuAAC reaction yields for 100% azide coated 
polymersomes.  
Although initial conjugation experiments were performed, there were subsequently issues 
with the reproducibility of the PBD-PEG polymersomes. The issues of reproducibility 
lead to the proposal of an alternative block copolymer platform. A triblock polymer, 
MeO-PEG-PEtGUV-PEG-OMe, previously shown to reproducibly form polymersomes, 
that could be functionalized with azide groups. A new MeO-PEG-PEtGUV-PEG-OMe 
(550) triblock and two azide functionalized triblock polymers, N3-PEG-PEtGUV-PEG-
N3 (600) and PEG-PEtGUV-PEG-N3 (1000), were produced and characterized. The self-
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assembly of MeO-PEG-PEtGUV-PEG-OMe and N3-PEG-PEtGUV-PEG-N3 triblock 
polymers individually and in mixtures led to the formation of nanoparticles that were too 
small to be imaged by CLSM. However, the mixture of a thermo-responsive analog 
triblock, MeO-PEG-PEtGThermo-PEG-OMe, and N3-PEG-PEtGUV-PEG-N3 yielded 
suspensions containing large polymersomes that could be imaged with CLSM along with 
smaller particles. CLSM could not be used to determine if the smaller particles were 
polymersomes or not. 
In terms of future work, the self-assembly protocol of MeO-PEG-PEtGThermo-PEG-
OMe and N3-PEG-PEtGUV-PEG-N3 mixtures must be optimized to achieve 
monodisperse samples of large polymersomes. These large polymersomes could then be 
functionalized with dye-labelled glycopolymers to determine the relative 
functionalization densities. The binding of the glycopolymer functionalized 
polymersomes could then be determined with lectin binding assays. Alternatively, if the 
small nanoparticles produced by N3-PEG-PEtGUV-PEG-N3 can be imaged with TEM 
and a vesicle morphology is observed, then they would be another candidate for further 
functionalization with glycopolymers. The next steps towards optimizing a PEtG 
containing triblock that can be self-assembled into polymersomes and functionalized with 
glycopolymers involves synthesizing triblock polymers with lower dispersities. Triblock 
polymers with lower dispersities would likely increase the reproducibility of 
polymersome formation by making the hydrophilic weight fraction more consistent 
within a polymer sample. Since hydrophilic weight fraction affects the morphology 
achieved with self-assembly, lower dispersities should make the self-assembly results 
more consistent. Reproducibly producing functionalizable polymersomes would create 
opportunities to take advantage of the tuneable degradation of the PEtG block. A system 
can be imagined where glycopolymers on the outside of a polymersome allow for 
specific targeting of a pathogen. After binding the pathogen, an enzyme, change in pH, or 
the presence of reducing agents at the surface of the pathogen could cause the 
degradation of the polymersome, releasing an anti-viral or anti-bacterial drug. 
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Appendices  
 
Figure A.0.1. 1H NMR Spectrum of PAGal19-Rho. (DMSO-d6, 400 MHz) 
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Figure A.0.2. 1H NMR Spectrum of crude AAcGal. (CDCl3, 600 MHz) 
 
Figure A.0.3. 1H NMR Spectrum of PSAcGal18. (CDCl3, 600 MHz) 
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Figure A.0.4. 1H NMR Spectrum of PSGal8-Rho. (D2O, 600 MHz) 
 
Figure A.0.5. 1H NMR spectrum of PBD-PEG-OH. (CDCl3, 400 MHz) 
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Figure A.0.6. 1H NMR spectrum of PBD-PEG-N3. (CDCl3, 600 MHz) 
 
Figure A.0.7. 1H NMR spectrum of N3-PEG-PEtGUV-PEG-N3 (600).(CDCl3, 600 MHz) 
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Figure A.0.8. 1H NMR spectrum of N3-PEG-PEtGUV-PEG-N3 (1000). (CDCl3, 600 
MHz) 
 
Figure A.0.9. FT-IR spectrum of SAcGal. 
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Figure A.0.10. FT-IR spectrum of N3-PEG-PEtG-PEG-N3 (1000). 
 
Figure A.0.11. SEC overlay of N3-PEG-PEtG-PEG-N3 (600) and N3-PEG-N3 (600). 
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Figure A.0.12. TGA trace of PSAcGal8. 
 
Figure A.0.13. DSC trace for PSAcGal8. 
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Figure A.0.14. Fluorescence Calibration Curve for PSGal8-Rho. 
 
Figure A.0.15. Fluorescence Calibration Curve for PSGal18-Rho. 
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Figure A.0.16. Rights and Permission to reprint Figure 1.4. 
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